DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Jänne PA, Shaw AT, Pereira JR et al.
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer.
Lancet Oncol 2013;
14: 38-47
We do not assume any responsibility for the contents of the web pages of other providers.